ATE227738T1 - Peptide und dessen verwendungen gegen psoriasis - Google Patents

Peptide und dessen verwendungen gegen psoriasis

Info

Publication number
ATE227738T1
ATE227738T1 AT95909258T AT95909258T ATE227738T1 AT E227738 T1 ATE227738 T1 AT E227738T1 AT 95909258 T AT95909258 T AT 95909258T AT 95909258 T AT95909258 T AT 95909258T AT E227738 T1 ATE227738 T1 AT E227738T1
Authority
AT
Austria
Prior art keywords
psoriasis
peptide
fragment
methods
peptides
Prior art date
Application number
AT95909258T
Other languages
English (en)
Inventor
Jennie C C Chang
Steven W Brostoff
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Application granted granted Critical
Publication of ATE227738T1 publication Critical patent/ATE227738T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
AT95909258T 1994-01-14 1995-01-13 Peptide und dessen verwendungen gegen psoriasis ATE227738T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/182,967 US6413516B1 (en) 1989-03-21 1994-01-14 Peptides and methods against psoriasis
PCT/US1995/000658 WO1995019375A1 (en) 1994-01-14 1995-01-13 Peptides and methods against psoriasis

Publications (1)

Publication Number Publication Date
ATE227738T1 true ATE227738T1 (de) 2002-11-15

Family

ID=22670842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909258T ATE227738T1 (de) 1994-01-14 1995-01-13 Peptide und dessen verwendungen gegen psoriasis

Country Status (14)

Country Link
US (1) US6413516B1 (de)
EP (1) EP0738281B1 (de)
JP (2) JPH09508112A (de)
CN (1) CN1138865A (de)
AT (1) ATE227738T1 (de)
BR (1) BR9506511A (de)
CA (1) CA2179280A1 (de)
DE (1) DE69528817T2 (de)
ES (1) ES2184791T3 (de)
FI (1) FI962836A7 (de)
MX (1) MX9602473A (de)
NO (1) NO962943L (de)
NZ (1) NZ279987A (de)
WO (1) WO1995019375A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0408164D0 (en) * 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
JP2009266963A (ja) * 2008-04-23 2009-11-12 Sumitomo Electric Ind Ltd 窒化物系発光素子、及び半導体発光素子を製造する方法
MX2021010857A (es) 2019-03-11 2021-12-15 Janssen Biotech Inc Anticuerpos biespecificos anti-v(beta17)/anti-cd123.
WO2022056197A1 (en) 2020-09-11 2022-03-17 Janssen Biotech, Inc. Immune targeting molecules and uses thereof
TW202227495A (zh) * 2020-09-11 2022-07-16 美商健生生物科技公司 用於調節β鏈介導之免疫的方法及組成物
EP4277645A1 (de) 2021-12-16 2023-11-22 Ramakrishna Reddy Isanaka Stabile antiangiogene und entzündungshemmende pharmazeutische formulierung und pharmazeutische kombination zur behandlung und prävention von psoriasis
CN116466095B (zh) * 2023-06-15 2023-09-01 朗肽生物制药股份有限公司 一种多肽及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570027B1 (de) * 1984-03-01 1999-12-29 The Board Of Trustees Of The Leland Stanford Junior University T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
IL95125A (en) * 1989-07-19 1995-07-31 Vandenbark Arthur Allen T cell peptides receive a method for their selection and preparation, and pharmaceutical preparations containing them
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
WO1993006135A1 (en) 1991-09-23 1993-04-01 Genentech, Inc. Diagnosing and treating autoimmune disorders
CA2126686A1 (en) * 1991-12-24 1993-07-08 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations

Also Published As

Publication number Publication date
AU697910B2 (en) 1998-10-22
US6413516B1 (en) 2002-07-02
EP0738281A1 (de) 1996-10-23
EP0738281B1 (de) 2002-11-13
CN1138865A (zh) 1996-12-25
AU1728295A (en) 1995-08-01
MX9602473A (es) 1997-05-31
DE69528817D1 (de) 2002-12-19
ES2184791T3 (es) 2003-04-16
FI962836L (fi) 1996-07-12
NO962943D0 (no) 1996-07-12
DE69528817T2 (de) 2003-09-11
NO962943L (no) 1996-09-13
JPH09508112A (ja) 1997-08-19
CA2179280A1 (en) 1995-07-20
BR9506511A (pt) 1997-09-09
FI962836A0 (fi) 1996-07-12
JP2001288108A (ja) 2001-10-16
FI962836A7 (fi) 1996-07-12
WO1995019375A1 (en) 1995-07-20
NZ279987A (en) 1999-09-29

Similar Documents

Publication Publication Date Title
Maggi The mammalian tachykinin receptors
FI972390A0 (fi) Sytokiini nimeltä Lerk-7
ATE282087T1 (de) Modifiziertes enzym mit lipolytischer aktivität
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
WO1999000410A3 (en) Human extracellular matrix proteins
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
WO2005076010A3 (en) Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
WO1998058958A3 (en) Human jagged polypeptide, encoding nucleic acids and methods of use
TR199701545T1 (xx) Yeni dolastatin t�revleri,haz�rlanmalar� ve kullan�mlar�
EP0871486A4 (de) Epitope von diphtheriatoxin
DE69635455D1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
MX9708791A (es) Gen de ataxia-telangiectasia y su organizacion genomica.
ATE227738T1 (de) Peptide und dessen verwendungen gegen psoriasis
DE69840509D1 (de) Apoptose-bezogene verbindungen und deren verwendung
DE69534419T2 (de) Intrazelluläre isoform von interleukin-1 rezeptor antagonist
ATE362983T1 (de) Menschlicher lysophosphatidsäure rezeptor und dessen verwendung
BG100939A (bg) Алфа-1-антихимотрипсинови аналози имащи еластазна инхибираща активност
NO952385D0 (no) Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen
CY1108126T1 (el) Μεθοδοι ελεγχου διαφοροποιησης και αναπτυξης κυτταρου χρησιμοποιωντας πρωτεϊνη συντηξης και ενα φαρμακο
WO2000028032A3 (en) Human cell surface receptor proteins
EP0870198A4 (de) Rekombinanter c140-rezeptor, seine agonsiten und antagonisten, und den rezeptor kodierende nukleinsäuren
WO1998055509A3 (en) Two human dnaj-like proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties